Tango Therapeutics (TNGX)
(Delayed Data from NSDQ)
$7.62 USD
+0.27 (3.67%)
Updated Sep 17, 2025 04:00 PM ET
Pre-Market: $7.82 +0.20 (2.62%) 9:16 AM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
TNGX 7.62 +0.27(3.67%)
Will TNGX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for TNGX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TNGX
Tango Therapeutics (TNGX) Soars 7.8%: Is Further Upside Left in the Stock?
Tango Therapeutics, Inc. (TNGX) Reports Q2 Loss, Lags Revenue Estimates
TNGX: What are Zacks experts saying now?
Zacks Private Portfolio Services
IGM Biosciences, Inc. (IGMS) Q2 Earnings and Revenues Surpass Estimates
Mirum Pharmaceuticals, Inc. (MIRM) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Wall Street Analysts Believe Tango Therapeutics (TNGX) Could Rally 61.46%: Here's is How to Trade
Other News for TNGX
Expansion Breakout appears for TNGX after 3.67% move
Major Stakeholder Sells Off Tango Therapeutics Shares in Multi-Million Dollar Deal
TNGX forms 20 Day Moving Average Support on September 16
Is TNGX building bullish momentum? Crossed Above 20 Day Moving Average shows up after advancing 4.44%
TNGX Fell Below 20 Day Moving Average on September 12